A midline for oxaliplatin infusion: The myth of safety devices
Authors: Masters, B., Hickish, T. and Cidon, E.U.
Journal: BMJ Case Reports
eISSN: 1757-790X
DOI: 10.1136/bcr-2014-204360
Abstract:Oxaliplatin is a platinum compound mainly used in the treatment of colorectal cancer. According to its manufacturer it is not considered vesicant agent though it has been shown to cause severe tissue damage if extravasation occurs in large doses. Several cases of extravasation have been reported; most of them from incorrectly placed peripheral cannula or incorrect use of central venous access devices. To reduce these risks, peripherally inserted central catheters and midline catheters have been increasingly used and are especially helpful if poor peripheral venous access. Midlines are mainly used for patients not receiving vesicant drugs, and are generally inserted without radiological guidance. They are believed to be safe, but we present the first ever-documented oxaliplatin extravasation injury from a midline catheter. Copyright 2014 BMJ Publishing Group. All rights reserved.
Source: Scopus
A midline for oxaliplatin infusion: the myth of safety devices
Authors: Masters, B., Hickish, T. and Cidon, E.U.Ñ.
Journal: BMJ case reports
Volume: 2014
eISSN: 1757-790X
DOI: 10.1136/bcr-2014-204360
Abstract:2014 BMJ Publishing Group Ltd. Oxaliplatin is a platinum compound mainly used in the treatment of colorectal cancer. According to its manufacturer it is not considered vesicant agent though it has been shown to cause severe tissue damage if extravasation occurs in large doses. Several cases of extravasation have been reported; most of them from incorrectly placed peripheral cannula or incorrect use of central venous access devices. To reduce these risks, peripherally inserted central catheters and midline catheters have been increasingly used and are especially helpful if poor peripheral venous access. Midlines are mainly used for patients not receiving vesicant drugs, and are generally inserted without radiological guidance. They are believed to be safe, but we present the first ever-documented oxaliplatin extravasation injury from a midline catheter.
Source: Scopus
A midline for oxaliplatin infusion: the myth of safety devices.
Authors: Masters, B., Hickish, T. and Cidon, E.U.
Journal: BMJ Case Rep
Volume: 2014
eISSN: 1757-790X
DOI: 10.1136/bcr-2014-204360
Abstract:Oxaliplatin is a platinum compound mainly used in the treatment of colorectal cancer. According to its manufacturer it is not considered vesicant agent though it has been shown to cause severe tissue damage if extravasation occurs in large doses. Several cases of extravasation have been reported; most of them from incorrectly placed peripheral cannula or incorrect use of central venous access devices. To reduce these risks, peripherally inserted central catheters and midline catheters have been increasingly used and are especially helpful if poor peripheral venous access. Midlines are mainly used for patients not receiving vesicant drugs, and are generally inserted without radiological guidance. They are believed to be safe, but we present the first ever-documented oxaliplatin extravasation injury from a midline catheter.
Source: PubMed
Preferred by: Tamas Hickish
A midline for oxaliplatin infusion: the myth of safety devices.
Authors: Masters, B., Hickish, T. and Cidon, E.U.
Journal: BMJ case reports
Volume: 2014
Pages: bcr2014204360
eISSN: 1757-790X
ISSN: 1757-790X
DOI: 10.1136/bcr-2014-204360
Abstract:Oxaliplatin is a platinum compound mainly used in the treatment of colorectal cancer. According to its manufacturer it is not considered vesicant agent though it has been shown to cause severe tissue damage if extravasation occurs in large doses. Several cases of extravasation have been reported; most of them from incorrectly placed peripheral cannula or incorrect use of central venous access devices. To reduce these risks, peripherally inserted central catheters and midline catheters have been increasingly used and are especially helpful if poor peripheral venous access. Midlines are mainly used for patients not receiving vesicant drugs, and are generally inserted without radiological guidance. They are believed to be safe, but we present the first ever-documented oxaliplatin extravasation injury from a midline catheter.
Source: Europe PubMed Central